Order Article Reprints

Sun C, Nagaoka K, Kobayashi Y, Nakagawa H, Kakimi K, Nakajima J. Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1. Cancers. 2021; 13(21):5508. https://doi.org/10.3390/cancers13215508

Sun, Changbo, Koji Nagaoka, Yukari Kobayashi, Hidewaki Nakagawa, Kazuhiro Kakimi, and Jun Nakajima. 2021. "Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1" Cancers 13, no. 21: 5508. https://doi.org/10.3390/cancers13215508

Sun, C., Nagaoka, K., Kobayashi, Y., Nakagawa, H., Kakimi, K., & Nakajima, J. (2021). Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1. Cancers, 13(21), 5508. https://doi.org/10.3390/cancers13215508